ADMA BIOLOGICS, INC. - 8-K Filing
ADMA Biologics held its 2026 Annual Meeting of Stockholders on June 2, 2026, where two Class I directors were elected with vote totals of 156.8 million for Alison C. Finger and 171.9 million for Eduardo Rene Salas; KPMG LLP was ratified as the independent auditor by a majority (198.7 million votes); and executive compensation received approval from shareholders, with 168.2 million voting in favor. (Items: 5.07 Submission of Matters to a Vote of Security Holders ADMA Biologics, Inc)
Tickers: $ADMA